MUCOSAL MELANOMA OF THE HEAD AND NECK
Clinical trials for MUCOSAL MELANOMA OF THE HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new MUCOSAL MELANOMA OF THE HEAD AND NECK trials appear
Sign up with your email to follow new studies for MUCOSAL MELANOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to fight rare nasal cancer before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether giving immunotherapy (Toripalimab) and chemotherapy (Temozolomide) before surgery can improve outcomes for people with a rare type of melanoma in the nasal cavity. The study will enroll 25 participants with resectable tumors. The main goal is…
Matched conditions: MUCOSAL MELANOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to stop rare Cancer's return
Disease control Recruiting nowThis study tests whether adding a drug called pembrolizumab to a special type of radiation therapy can help prevent mucosal melanoma from returning after surgery. About 20 people with this rare head and neck cancer will receive the combination. The goal is to see if this approach…
Matched conditions: MUCOSAL MELANOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC